MENU

Fox Chase-Temple Bone Marrow Transplant Program Recognized for Excellence

December 20, 2019

In a review performed by the Center for International Blood & Marrow Transplant Research (CIBMTR), of the 180 transplant centers in the United States, only 12 adult and five pediatric centers were rated as performing above expectations.  “We manage our patients together and this contributes significantly to the superior outcomes,” said Henry Fung, MD, FRCPE, director of the transplant program. “Our patient survivals compared favorably to most transplant centers across the country.”In a review performed by the Center for International Blood & Marrow Transplant Research (CIBMTR), of the 180 transplant centers in the United States, only 12 adult and five pediatric centers were rated as performing above expectations. “We manage our patients together and this contributes significantly to the superior outcomes,” said Henry Fung, MD, FRCPE, director of the transplant program. “Our patient survivals compared favorably to most transplant centers across the country.”

PHILADELPHIA (December 20, 2019) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has been recognized for performing better than expected for successful transplant procedures, according to a recent analysis. Fox Chase was the only adult center in the tristate area to achieve this distinction. The only other center in Pennsylvania to be recognized was the UPMC Children’s Hospital of Pittsburgh.

In a review performed by the Center for International Blood & Marrow Transplant Research (CIBMTR), of the 180 transplant centers in the United States, only 12 adult and five pediatric centers were rated as performing above expectations.

“We manage our patients together and this contributes significantly to the superior outcomes,” said Henry Fung, MD, FRCPE, director of the transplant program. “Our patient survivals compared favorably to most transplant centers across the country.”

As part of the requirements established for tracking stem cell therapy in the United States, the CIBMTR performs these annual surveys of patient outcome and survival data for all allogeneic transplants to measure the quality of care and treatment.  

Started in 1990, the Fox Chase-Temple BMT program performs over 100 blood and bone marrow transplants a year, procedures that improve long-term outcomes for patients with blood-related disorders and blood cancer.

The state-of-the-art facility at Jeanes Hospital, which is adjacent to Fox Chase, allows Fung and his multidisciplinary team to provide excellent comprehensive care throughout treatment. Physicians and nurses are specially trained in blood and bone marrow transplantation procedures and can provide an array of treatment options tailored to each patient.

In addition to the expert medical care, the program offers opportunities for patients and their caregivers to access resources that can assist with some of the challenges associated with blood and bone marrow transplants.  

Fung emphasized the importance of this personalized, hands-on approach to treatment and is proud of his team’s efforts to provide the highest quality care. “We work closely with the transplant recipients and caregivers before, during, and after the transplant. They are always part of the team.”

As a hematologist-oncologist, Fung focuses on stem cell transplant therapy for patients with leukemia, lymphoma, and other life-threatening blood disorders. He attributes much of the BMT program’s excellence to the dynamic and nuanced care the center is able to provide.

Fung believes much of the center’s continued success will be due to a robust quality improvement program that provides it with continuous feedback on their quality of care. “We can always do better,” he said.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase